TechBooky AI Assistant
TechBooky AI Assistant
👋 Welcome to TechBooky AI Assistant

I can help with:
🔎 Tech News
🤖 AI Topics
💻 Gadgets
☁️ Cloud
✍️ Guest Posts
📢 Advertising
🔗 Backlinks
📩 Newsletter
  • AI Search
  • Cryptocurrency
  • Earnings
  • Enterprise
  • About TechBooky
  • Submit Article
  • Advertise With TechBooky
  • Contact Us
  • Data Intelligence
TechBooky
  • African
  • AI
  • Metaverse
  • Gadgets
  • Data Intelligence
  • AI Search
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
  • African
  • AI
  • Metaverse
  • Gadgets
  • Data Intelligence
  • AI Search
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
TechBooky
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages

Molecule.one Raised $4.6m To Bring Theoretical Drug Molecules To Reality

Ibhadojemu Emmanuel by Ibhadojemu Emmanuel
June 2, 2021
in Uncategorised
Share on FacebookShare on Twitter
Share this story

Send it to someone who should read it.

f Facebook X X in LinkedIn wa WhatsApp tg Telegram @ Email
In Brief
  • Molecule.one is a Polish computational chemistry outfit that makes universal working environment software for synthetic planning chemists.
  • The company has raised the sum of $4.6 million in its latest funding round and plans on using this fund to fuel its plans of bringing...
  • The company’s machine learning systems operate by predicting the most suitable and viable ways of synthesizing potentially valuable molecules which is an important part of creating...

Molecule.one is a Polish computational chemistry outfit that makes universal working environment software for synthetic planning chemists.

The company has raised the sum of $4.6 million in its latest funding round and plans on using this fund to fuel its plans of bringing theoretical drug molecules to life. The company’s machine learning systems operate by predicting the most suitable and viable ways of synthesizing potentially valuable molecules which is an important part of creating new drugs and treatments for diseases.

The company was part of the Disrupt SF 2019 Startup Battlefield. It was on this platform that Molecule.one described the challenges that the drug discovery industry is faced with. The company explained that many companies in the drug discovery industry can come up with treatments in theory but are faced with the challenge of making the molecules.

Also worth reading
OpenAI Tests Whether AI Can Pick Promising Drug Candidates Opinion: Your Private Chats Should Not Become AI Training Ground AI Weapons Talks End Without Binding Rules as Geneva Misses Treaty Mandate Signal Blocks Siri and Gemini From Reading Private Chats Trump Threatens Tax on US Firms Building AI Data Centres Abroad Anthropic Mathematician Claims Claude Helped Prove Riemann Hypothesis

Now this is how Molecule.one works! When there is a new compound that probably no one has enough knowledge about that needs to be made and tested, this is where the company’s machine learning systems come in. The company works by creating a workflow that starts with everyday chemicals and provides step-by-step guidelines using already established methods to transcend from one point to another, and another.

The company’s CSO – Stanislaw Jastrzebski explained that the company leverages machine learning and vast knowledge of already established chemical reactions to create a process. “Synthetic planning can be characterized as a game. In each move of this game, instead of moving a piece on a board, we break a chemical bond between a pair of atoms. The goal of the game is to break down a target molecule to molecules that can then be bought on the market and used to synthesize the target. We use algorithms similar to the ones used by DeepMind to master Go or chess to find the synthetic pathway”, he explained.

Startups like Molecule.one gives hope to the future of medicine.

Related Reading

More contextual TechBooky stories selected from tags, categories and article context.

  • Multiply-Labs
    Multiply Labs Raises $75M To Bring Robots Into Drug…
  • miles wang
    OpenAI Researcher's $2B Drug Discovery Plan Shows AI…
  • introducing-medchembench-header-poster-4k
    OpenAI Tests Whether AI Can Pick Promising Drug Candidates
  • 1776370209_gpt-rosalind
    OpenAI Unveils GPT-Rosalind, Aiming at Drug…
  • 1688385382185
    39 US AI firms raised $100M+ in 2024: Full list
  • rebellions
    Rebellions Secures $400M, Hitting $2.3B Valuation Before IPO
  • tae-technologies-norman-employees-option-4-forprint-1660242072
    Google-Backed Fusion Startup Moves to Commercialize…
  • DotOrg_2_1.width-1200.format-webp
    Google.org Pledges $20M for AI Science Research
Keep Reading Smarter

Search TechBooky with AI

Use TechBooky's AI Search to explore the context behind this story and related coverage across the site.

Try AI Search
Follow TechBooky

Follow TechBooky for more technology stories and newsroom updates.

f Facebook X X in LinkedIn ig Instagram wa WhatsApp

Ibhadojemu Emmanuel

Ibhadojemu Emmanuel

Ibhadojemu Lucky Emmanuel is a graduate of Education and Economics from the University of Benin. He has a passion for tech and business and has been writing professionally for over a period of five years. He's written across various topics and segments and knew tech-business was it when he first stumbled on it. He has a great passion for music and arts, and wants to visit as many countries as he can someday.

Search TechBooky
Open TechBooky AI Search Try the AI Assistant

BROWSE BY CATEGORIES

Receive top tech news directly in your inbox

subscription from
Loading

Freshly Squeezed

  • Opinion: Your Private Chats Should Not Become AI Training Ground November 22, 2026
  • AI Weapons Talks End Without Binding Rules as Geneva Misses Treaty Mandate November 22, 2026
  • Signal Blocks Siri and Gemini From Reading Private Chats November 22, 2026
  • Trump Threatens Tax on US Firms Building AI Data Centres Abroad November 21, 2026
  • OpenAI Tests Whether AI Can Pick Promising Drug Candidates November 21, 2026
  • Anthropic Mathematician Claims Claude Helped Prove Riemann Hypothesis November 21, 2026
  • Nvidia Accounting Practices Under SEC Scrutiny, Reuters Says November 21, 2026
  • White House Names Kirsten Davies as Cyber Director Amid Outage Concerns November 20, 2026
  • Apple Job Listings Point to AI Agent That Can Work Across Apps November 20, 2026
  • Anthropic IPO Shares Give Back Early Gains as AI Stocks Sell Off November 20, 2026
  • Nigeria Selects Eight Startups for iDICE Growth Lab With Up to $100K Each November 20, 2026
  • AWS Lambda Doubles On-Demand Event Function Limit to 30 Minutes November 20, 2026

Browse Archives

November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Oct    

Quick Links

  • About TechBooky
  • Advertise With TechBooky
  • Contact us
  • Submit Article
  • Privacy Policy
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
  • AI
  • Data Intelligence
  • AI Search
  • African
  • Gadgets

© 2025 Designed By TechBooky Elite

Discover more from TechBooky

Subscribe now to keep reading and get access to the full archive.

Continue reading

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.